HOCHLÖSLICHE LEPTINE
European patent · EP3241558 · In force
Register entry
- Publication number
- EP3241558
- Application number
- EP17163203
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 28, 2011
- Published
- Nov 8, 2017
- Granted
- Mar 3, 2021
- Protection ends at the latest
- Sep 27, 2031
- Next annual fee due
- Sep 30, 2027
- IPC classes
- C07K 14/575 (2006.01)A61K 38/22 (2006.01)A61P 3/00 (2006.01)A61P 3/04 (2006.01)A61P 3/08 (2006.01)A61P 3/10 (2006.01)A61P 25/28 (2006.01)A61P 1/16 (2006.01)
- Priority
- US 387402 P 28.09.2010US 422091 P 10.12.2010
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Oct 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.09.2025 → 30.09.2026
Published in Swissreg on 01.10.2025
- Oct 3, 2024
Change
Published in Swissreg on 03.10.2024
- Oct 1, 2023
Change
Published in Swissreg on 01.10.2023
- Oct 1, 2022
Change
Published in Swissreg on 01.10.2022
- Jan 12, 2022
Change
Published in Swissreg on 12.01.2022
- Jun 25, 2021
Address changed
- Owner
- Aegerion Pharmaceuticals, Inc., One Main Street, Suite 800, Cambridge, MA 02142, USA → Amryt Pharmaceuticals, Inc., One Main Street, Suite 800, Cambridge, MA 02142, USA
Published in Swissreg on 25.06.2021
- Mar 5, 2021
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in Swissreg on 05.03.2021
1 earlier entry
- Mar 3, 2021
Granted
Published in Swissreg on 03.03.2021
Parties
Inventor
San Diego, CA California 92121, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.